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 Abstract 
 
Given their particular morphology, comprising a cell body from which they extend very long 
structures such as axons, neurons require a system of intracellular communication that is able to 
carry the biochemical signal over considerable distances. For example, a signal initiated at the 
axon terminal must be transmitted to the cell body, where an adequate response will follow. 
Neurotrophins exploit this signaling mechanism. It is now well established that they travel along 
axons using “signaling endosomes”, endosomal vesicles generated by the internalization of, for 
example, activated neurotrophic receptors bound to their ligands, capable of transporting the 
biochemical signal at long distances. These particular organelles contain numerous metabolic 
effectors, such as protein kinases, and their composition is dynamic in time and space, allowing 
precise and diverse transduction responses. 
Neurotrophins are growth factors critical to the functionality of neurons. These proteins 
contribute to the growth, differentiation and survival of neuronal populations during development 
and in the adult stage. The first discovered neurotrophin is the Nerve Growth Factor (NGF).  
NGF is obtained following the cleavage of its precursor form: proNGF. Although for many years it 
was thought that the mature form of NGF was the only biologically active, recent findings have 
suggested that even the proNGF has its own specific activity. The proNGF can be cleaved both 
inside and outside the cells, thus acting as a source of NGF, or may remain unprocessed, 
respectively activating survival/differentiation or apoptosis pathways. It has been shown that the 
NGF and proNGF activate different and specific gene expression profiles when individually 
administered to cell cultures. So, mutual levels of NGF and its precursor form constitute a 
discriminant in the survival/death balance of several neuronal populations in physio-pathological 
conditions. The loss of this delicate balance can lead to neurodegeneration, as evidenced by the 
increase of the level of proNGF in the cerebral cortex of patients affected by Alzheimer's disease.  
Understanding the molecular mechanisms underlying NGF versus proNGF internalization and 
characterizing their differential interaction with their biological partners is crucial to shed light on 
the process of survival/death choice of the neurons, not only in pathological conditions but also as 
a basic mechanism of neuronal functioning.  
Axonal trafficking of neurotrophins has been studied over the years, but an effective strategy for 
this purpose requires a precise and non-invasive labeling methodology. In this work, a small 
peptide tag was inserted into the C-terminus of human proNGF sequence, which acts as a site for 
the specific enzymatic labeling of these neurotrophins via covalent conjugation to fluorescent-CoA 
derivates. Tagged proNGF was expressed in E. coli, purified from inclusion bodies and then 
refolded. Tagged NGF was obtained by controlled proteolysis of precursor form. After in vitro 
labeling reaction, fluoproNGF and fluoNGF were HPLC purified and functionally validated through 
microarray analysis. Fluorescent neurotrophins were individually administered to differentiated 
PC12 cells. Differences and similarities of their endocytic pathways were then investigated by 
immunofluorescence against various protein partners followed by semi-automated colocalization 
analysis.
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1. Introduction 
1.1. NGF physiology 
Neurons are cells with a peculiar architecture, which differs from that of the other cellular types. 
In fact, although their cell body is in the range of tens of micrometers, neurons often possess vast 
dendritic branches and an axon that can reach a length equal to thousand times the diameter of 
the cell body. This morphology implies the presence of a highly efficient transport system of 
biochemical signals that enables intra- and inter-cellular communication. Within a neuron, this 
communication mechanism, called axonal transport, can be divided mainly into two categories: 
anterograde and retrograde. Anterograde transport is used by the neuron for moving components 
such as proteins, largely synthesized in the cell soma, to the axon terminal. Besides proteins, this 
transport involves components such as mRNAs, lipids, synaptic vesicles and mitochondria. On the 
other hand, retrograde axonal transport is responsible for carrying molecules and organelles 
destined for degradation from the axonal terminal back to the cell body. In addition, retrograde 
axonal transport also delivers target-derived chemical and biological signals to the cell body for 
effective communication between neurons and cells innervated by these (target cells), such as in 
the neurotrophin retrograde signaling process1.  
Neurotrophins are a family of proteic growth factors, released by target tissues of neurons such as 
skin, glands, muscle, or brain. These proteins perform many functions. For example, they are 
essential to the development, differentiation and maintenance of neurons, as well as for proper 
neuronal subtype specification and for the formation of neural circuits. Finally they help neurons 
to respond to axonal injury. Thus, these molecules play a crucial role in the proper functioning of 
the nervous system. 
NGF was discovered in a context of research aimed at understanding the relationships between 
developing neurons and their innervated tissues. In particular, in the late 1940s, Viktor Hamburger 
and Rita Levi Montalcini demonstrated that the removal of the limb primordia in chicken embryos 
caused hypoplasia of correspondent neural center (i.e., spinal ganglia), while implantation of 
additional wing or leg buds caused hyperplasia2. Subsequently it was observed that 
transplantation of a murine tumor in a chicken embryo produced the same type of hyperplasia, 
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although the nerve fibers were not able to establish synaptic connections with tumor cells3. 
Additional in vitro experiments have made clear that this factor had soluble nature, and that it was 
capable of stimulating neuronal growth through a kind of ‘’metabolic exchange’’ between the two 
cell types. These discoveries led to the formulation of the ‘’Neurotrophic Factor Hypothesis’’4. The 
protein responsible for these phenomena was identified and characterized by Rita Levi Montalcini 
and Stanley Cohen, it was called Nerve Growth Factor5.  
With the progress of the discoveries it is becoming clear that the world of neurotrophins has an 
impressive complexity. Both NGF and its receptors are produced during development, adult life, 
and aging by many cell types in the CNS and PNS (Central and Peripheral Nervous System 
respectively). During development, expression of NGF by target cells is compatible with its role as 
a tropic factor for neurons, stimulating the axonal extension in the direction of the target. The 
small amount of neurotrophin produced triggers a mechanism of competition between neurons, 
which will allow the survival of only those who receive a sufficient quantity of growth factor 
(trophic action). In adult neurons, after the differentiation is completed, the NGF allows the 
maintenance of differentiated phenotype and of synaptic connections. Adult sympathetic and 
sensory neurons are less vulnerable to NGF deprivation than during development and single 
injections of antibodies against NGF result only in transitory degenerative changes6,7. 
NGF-responsive neuronal cells are: sympathetic neurons, a subpopulation of sensory neurons of 
the dorsal root ganglia (DRG), and the basal forebrain cholinergic neurons in the central nervous 
system. However, NGF is also involved in immune and inflammatory responses. It is important for 
a variety of cells such as lymphocytes, mast cells and eosinophils. It was also found in the mouse 
submandibular gland, playing a key role in intraspecific fighting8.  
The need for this trophic factor varies depending on the cell type and also changes over time, 
leading to the switching of neurotrophins requests. Many neurons require more than one 
neurotrophic factor-receptor signaling pathway to survive. In the vast majority of cases, this 
appears to reflect requirements at different developmental stages. Subsets of DRG neurons and 
trigeminal ganglion neurons loose responsiveness to NGF and become responsive to another 
neurotrophic factor called GDNF (Glial cell-derived neurotrophic factor)9.  
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1.2. proNGF physiology 
Like most growth factors, neurotrophins are initially synthesized as precursors or 
proneurotrophins consisting of an N-terminal prodomain upstream the mature domain. The NGF 
can be secreted as a mixture of the mature form and its precursor proNGF. The latter has its 
precise molecular identity, it plays different and generally divergent roles compared to NGF. 
proNGF levels are very low in the CNS and PNS of uninjured young adult rodents10,11. However, 
several studies indicate that proNGF levels are upregulated in adults of advanced age. 
Furthermore, the common scenario foresees the increase of the level of proneurotrophins after 
brain damage and even in neurodegenerative phenomena. In fact, proNGF has been found to be 
present at high levels in several areas of aged brain12, in Alzheimer Disease (AD) brain13 and in 
injured adult CNS14,15. Although it would be tempting to generate a genetically manipulated mouse 
that lacks the prodomain of NGF as a means to discriminate proNGF from mature NGF function, 
this is not an effective strategy as the prodomains of neurotrophins are required for efficient 
protein folding and intracellular trafficking16. However, a selective imbalance of proNGF vs NGF, 
induced by the expression of an NGF-specific antibody, was found to cause the progressive AD-like 
neurodegeneration in the brain of these transgenic mice17.  
1.3. Biochemistry of (pro)NGF and its receptors 
In mammals, the family of neurotrophins includes: NGF, BDNF (Brain Derived Neurotrophic 
Factor), NT3 (Neurotrophin 3) and NT-4/5 (Neurotrophin 4/5). Mature neurotrophins bind with 
high affinity to Trk receptors, a family of tyrosine kinases that includes TrkA, TrkB, and TrkC. The 
binding is highly specific: NGF binds preferentially to TrkA, BDNF and NT4 to TrkB, and NT3 to TrkC. 
NT3 also binds with low affinity to TrkA and TrkB. Individual Trk receptors mediate the survival of 
specific subpopulations of neurons. TrkA null animals show profound loss in superior cervical, 
dorsal root and trigeminal ganglion neurons.18  
 In addition, all neurotrophins bind to a common low-affinity receptor p75. As a general principle, 
binding to Trk receptors supports signals for neuronal survival, axonal growth, and target 
innervation, whereas p75 binding promotes neuronal degeneration, growth cone collapse, and the 
inhibition of axonal regeneration1.  
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NGF and proNGF 
The human NGF gene is located on the short arm of chromosome 1, it transcribes two major 
alternatively spliced transcripts, from which two isoforms of 34 and 27 kDa (pre-pro species) are 
translated. The signal peptide, mediating secretion, is cleaved upon translocation into the 
endoplasmic reticulum, giving rise to the two proNGF species of 32 and 25kD19. proNGF contains 
three potential glycosylation sites, two in the pro segment and one in the mature sequence, both 
glycosylated and non-glycosylated forms being present physiologically. From the endoplasmic 
reticulum, the proNGF present in the form of a homodimer can be secreted out of the cell or can 
be processed to mature NGF upon cleavage downstream an Arg (-1) at the N-terminal. Furin 
convertase is able to process proNGF at its amino-terminus in the trans-Golgi network20. 
Extracellular processing is performed by proteases, such as plasmin and matrix metalloprotease-
721. However, shorter peptides were also identified. These shorter forms are produced by removal 
of 8 or 9 amino-acids at the N-terminal of NGF (in mouse or in human respectively), and by 
removal of the C-terminal arginine22 (demonstrated only in the mouse submandibular gland). 
From the shorter transcript (B in figure) the two active neurotrophins forms are synthesized: 
proNGF, a ∼50 kDa homodimer and NGF, a ∼26 kDa homodimer (figure 1 B).  
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Figure 1. Primary structure of proNGF. A) proNGF amino acidic sequence. The arrow represents 
the cleavage site between the pro and the mature region23. B) Intermediates in NGF biosynthesis. 
Figure taken by Fahnestock et al., 200421.  
Both mature NGF and proNGF exist in their active forms as homodimers. NGF polypeptide 
contains 118 amino acids with 3 intrachain disulphide bonds. The crystal structure was obtained in 
1991. It is made up of two monomers interconnected in a non-covalent manner by a cysteine knot 
structure, which produces a winding of beta chains around each other. This structural core 
identifies the family of neurotrophins. The pro-domain, constitute by 103 amino acids has an 
intrinsically disordered structure. 
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Figure 2. proNGF structure. Model of proNGF structure built according to SAXS (Small-angle X-ray 
scattering) data. Mature NGF is shown in gray, pro domain in red. The side chain of NGF Trp21 is 
shown in green. This residue was suggested to take part to the interaction of the NGF moiety with 
the pro-peptide24. 
  
Neurotrophin receptors 
TrkA receptor is the main receptor responsible for NGF signalling. It belongs to the Tropomyosin 
receptor Kinases family, together with TrkB and TrkC. This single pass type 1 receptor is 
characterized by an extracellular portion consisting of two cysteine-rich domains, separate by 
three leucine-rich repeats. The juxtamembrane segment contains two immunoglobulin-C2 (Ig) 
domains, by which the receptor binds the neurotrophin. Intracellularly, TrkA possesses a tyrosine 
kinase domain. Ligand binding results in receptor dimerization and trans-phosphorylation. Three 
phosphorylated tyrosine residues serve as docking site for the activation of various partners 
involved in downstream kinase cascades.  Trks are mainly responsible for the neurotrophin-
mediated survival response of neurons.  Although this last feature is well recognized in PNS during 
development, Trks play this and many other actions also in CNS, where neurons do not necessarily 
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need target-derived neurotrophic support. In fact, TrkA is involved in a number of processes such 
as neuronal growth and arborization, as well as the strengthening of synaptic transmission. 
Furthermore, it is not uniquely associated with the nervous system, due to its presence in tissue-
like vasculature.  The molecular machinery that underlies these processes involves the activation 
of three main metabolic pathways: i) PLC-gamma, leading to intracellular Ca++ release and 
activation of Protein Kinase C ; ii) phosphatidylinositol 3-kinase/Akt, thus activating mTOR and 
contrasting 4E-BP1; iii) Ras-extracellular signal-regulated kinase (Erk), then promoting MEK/Erk 
signaling and in turns transcriptional events associated with c-Fos and CREB18.  
 
Another receptor with key role in the signaling of neurotrophins is p75NTR, a member of the 
tumour necrosis factor receptors superfamily. p75 is capable of binding all four mammalian 
neurotrophins, bearing higher affinity for their unprocessed precursor forms. This receptor exerts 
a multitude of independent and somehow contrasting actions depending on the cellular context. 
This fascinating protein, in fact, is involved in processes such as: axonal growth and degeneration, 
neuronal proliferation, differentiation, myelination and synaptic plasticity. Finally, it is able to 
assist the survival action of neurotrophins, or induce apoptosis in cells (discussed below). 
Structurally, p75NTR is a type I transmembrane protein, consisting in a glycosylated cysteine-rich 
extracellular domain, with which it binds neurotrophins, and an intracellular Type 2 “death 
domain”, similar to that found in other TNFR proteins or in the Fas antigen. p75NTR promotes 
downstream death signaling events via association with various  cytosolic interactors, for example 
leading to c-jun kinase (JNK) activation, and subsequent p53, Bax-like proteins and caspase 
activation. It can also inhibit neurite outgrowth by blocking the activity of Rac, a cytoskeletal 
remodeler. 
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Figure 3. Schematic representation of the Trks and p75 receptors. In the Trks structure CRD is the 
cysteine-rich domain, LRR is the leucine-rich repeats, IgL is the immunoglobulin-C2 (Ig) domain and 
TKD is the tyrosine kinase domain. In the p75 structure are show the four cysteine-rich domain 
and the intracellular chopper and death domain (respectively CD and DD). 
Another protein of fundamental importance for neurotrophins signaling is Sortilin. It belongs to a 
VPS10P domain receptors family, together with SorLA, and SorCS1–3. Sortilin acts on two fronts, it 
participates in intracellular protein sorting and also in cell signaling. Although initially this protein 
was seen only as an actor of lysosomal targeting, due to its intracellular tail motif involved in 
protein sorting, sortilin actually plays a vital role in the signaling of the neurotrophins, thereby 
affecting the cellular response in different contexts. Structurally, it is a type 1 transmembrane 
receptor, with the extracellular portion constituted by the VPS10p domain. This domain is the 
mammalian homologue of a domain involved in lysosomal targeting of proteins in yeast, and it has 
the function to bind the pro-domain of neurotrophins. Sortilin also owns a transmembrane portion 
and a cytosolic tail important for the sorting of proteins in different intracellular compartments. 
The biology of Sortilin is complex, since it can assist p75 in mediating cell death signal, and at the 
same time promotes the trophic signal, facilitating the anterograde axonal transport of Trks 
receptors, thus increasing the supply of these receptors at the axonal tip18.  
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1.4. Dynamic interplay between neurotrophins and their 
receptors  
Initially the action of neurotrophins was thought to follow a fairly linear process: the protein is 
synthesized in the form of immature precursor, its processing makes the mature form available, 
and this will account for the survival of neurons. Loss of these factors would cause neuronal death. 
Actually the signaling of neurotrophins occurs in a much more complex scenario. In fact, both the 
various isoforms of neurotrophins and their respective receptors interact in a non-obvious 
manner, producing diversified and sometimes unexpected cellular responses. One should envisage 
an intricate network system, in which not only the molecular identity, but also the stoichiometry 
and dynamics between various proteins taking part to the same molecular complex, alter the 
balance between possible death or survival signaling outcomes.  
As it regards NGF, basic mechanism foresees promoting of survival response through binding with 
TrkA. Both affinity and signaling of TrkA in response to NGF are potentiated in presence of 
p75NTR, which acts as co-receptor. Numerous studies have been conducted in order to 
characterize the molecular interactions involving NGF, p75 and TrkA. Although it has been 
proposed, the existence of this ternary complex is debated, because evidence of a direct 
interaction among these three components is still elusive. Also, the nature of this complex is 
difficult to reconcile with the structural data, which indicate that the NGF dimer binds separately 
to the two receptors with opposite orientations. Two main models were proposed for this 
interaction. The “ligand-passing model”, in which NGF initially binds P75, this step favors the 
exposure and then the binding of neurotrophin to TrkA25 (figure 4).  
 
Figure 4. Ligand-passing model25. 
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In the second model, instead, two dimers of NGF will be associated in the opposite direction to 
form a “dimer of dimers”, in agreement with crystallographic data. The protein complex would 
therefore be composed of TrkA/NGF/P75 in a (2:4:2) stoichiometry26.  
The classic signaling of proNGF contemplates its binding with Sortilin through the pro domain, 
while the mature part binds the P75 receptor. The complex is then internalized and activates the 
processes necessary to neuronal death. The molecular interactors downstream this signaling are 
not well understood, although it is known that proteins such as TRAF6, Nrif, MAGE and NRAGE 
bind the cytoplasmic domain of p75. It is noteworthy that proNGF induces intracellular cleavage of 
p75, the resulting fragment binds to Nrif and translocates to the nucleus, where it will promote 
apoptosis.  
The mechanisms described above, constitute only a part of the complex network of interactions 
that characterizes this biological system. In fact, numerous experiments have allowed to find 
alternative and sometimes unexpected signaling mechanisms. For example, mature 
neurotrophins, classically considered as survival factors, can also have opposite effects. Barde and 
collegues showed that the administration of NGF in cultured neurons that lack TrkA, causes cell 
death through P7527. However, high concentrations of neurotrophin used suggest that this does 
not happen physiologically, and that the mediator of apoptosis is most likely proNGF, active at 
much lower concentrations28. Other research suggests that the presence of only p75 lead to 
apoptosis. For example, the sympathetic neurons express P75 and TrkA, but not TrkB. The 
administration of NGF to these cells induces survival response, while if exposed to BDNF cell 
deaths occurs, due to the lack of specific tyrosine kinase receptor29. In the same way, also the 
proNGF possesses unexpected properties, in fact it can bind TrkA with low affinity, and act as a 
neurotrophic factor, although the survival response is less marked21.p75 plays a pivotal role in the 
regulation of the survival/death balance. On one hand, p75 knockout mice show a 50% reduction 
in the number of neurons in the DRG. These ganglia consist of a very heterogeneous neuronal 
population, comprising TrkA, TrkB and TrkC positive neurons. Clearly, therefore, the enhancement 
of Trks signaling is mediated by the p75NTR receptor30. The mechanism by which P75 promotes 
the survival signaling is not known, it is possible that this co-receptor attenuates the degradation 
of TrkA mediated by ubiquitin31. On the other hand, P75 is best known for his role in apoptosis. 
This property would seem closely related to the action of proNGF32.  
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Certainly, therefore, the proNGF/NGF ratio is a decisive discriminant in the choice made by the 
neuron. AD11 mice provide an excellent model for testing this aspect, as these animals express a 
specific antibody against the NGF, thus impairing the ratio of precursor neurotrophin and its 
mature counterpart. This imbalance causes progressive Alzheimer-like neurodegeneration in the 
brains of these transgenic mice17. 
However, there is another protein to consider, Sortilin. Despite its known role as a co-receptor of 
P75 crucial for death signaling in response to proneurotrophins, recent evidence suggests that 
Sortilin is involved in the neuronal survival process. In 2011, Nykjaer and colleagues have shown 
that: i) TrkA-, TrkB-, and TrkC-positive DRG neurons are all lost to the same extent (40–60 %) in 
p75NTR null mice; ii) genetic deletion of Sortilin had no effect on DRG neurons survival; iii) 
surprisingly P75/Sortilin double Knockout mice show more severe DRG neuronal loss than that 
observed with p75NTR deletion alone33. The mechanism by which Sortilin contributes to the 
trophic signaling is not known. In this same study, it was shown that Sortilin is physically 
associated with TrkA (Co-Immunoprecipitation experiments) and facilitates its anterograde axonal 
transport, thus enhancing its axonal targeting.  
The combined observations suggest the tripartite model for neurotrophin signaling illustrated in 
figure 5 (“the neurotrophin triangle”): Sortilin is essential to form a death complex with p75NTR 
activated by proNT. Signaling by Trk receptors, conversely, requires p75NTR on the plasma 
membrane to facilitate binding of NT and to strengthen trophic signals. To complete this triangular 
interaction, sortilin supports and fine-tunes trophic signaling by facilitating anterograde Trk 
transport along the axonal path18.  
 
Figure 5. The neurotrophin triangle. 
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Figure 6. Pro- and anti-apoptotic signaling by (pro)neurotrophins. (Left) Pro-neurotrophins 
(proNTs) may signal cell death through sortilin/p75NTR complexes in conjunction with 
neurotrophin receptor-interacting MAGE homolog (NRAGE) resulting in activation of c-Jun NH2-
terminal kinase (JNK) 3 and caspases (Casp) 3, 6 and 9 (step 1), or in a non-cell autonomous 
manner by release of tumor necrosis factor (TNF) a (step 2). Activation of the death receptor 
complex may also entail regulated intramembrane proteolysis of p75NTR producing the carboxyl 
terminal fragment (CTF) by JNK3-mediated tumor necrosis factor-a-converting enzyme 
(TACE)/disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) induction (step 
3), followed by g-secretase-mediated release of the soluble intracellular (ICD) (step 4). CTFs 
activate the G-protein-coupled inwardly rectifying potassium channel (GIRK) through Rac (step 5) 
[63]. The ICD forms a complex with neurotrophin receptor interacting factor (NRIF) and tumor 
necrosis factor receptor associated factor 6 (TRAF6) to promote ubiquitination of NRIF and nuclear 
translocation, in addition to further amplifying the activation of JNK3 (step 6). (Right) Cell survival 
signals through NTs are conveyed by Trk receptors or by Trk/p75NTR complexes acting through 
phospholipase C gamma (PLCγ), ras-mitogen-activated protein (MAP) kinase, and the 
phosphoinositide-3 (PI3) kinase-Akt pathways (step 7). Sortilin critically contributes to NT signaling 
by anterograde sorting of Trk molecules to the cell surface (step 8). Trk-dependent NT signaling 
through Akt is counteracted by proNT-induced induction of PTEN, blocking PI3 kinase and 
integrating pro- and apoptotic signaling pathways (step 9) (figure taken from Nykjaer and Willnow 
2012)34. 
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1.5. Axonal transport 
Commonly, the general mechanism of signal transduction involves the activation of proteins, such 
as receptors on the cell membrane, and successive waves of signal propagation such as kinase 
cascades. Initially it was believed that this mechanism also governs the action of neurotrophins. 
Although this view persists in part, it is clear that the simple diffusion of proteins through the 
neuronal cytoplasm seems to be little efficient as a signaling mechanism in cells with a so 
extensive architecture. Despite numerous researches have been carried out, the nature of this 
molecular mechanism is still debated.  
Several mechanisms have been proposed, then, for this long-distance communication. The “wave 
model” suggests that NGF binds to and activates surface TrkA at distal axonal terminals. The signal 
would then be carried by activated TrkA or by interactors through a rapid lateral propagation in 
the plasma membrane35. The “signaling effector model” proposes that second messengers (i.e. 
calcium flux or downstream kinases) are transported retrogradely without the need for the 
persistent presence of the ligand or receptor36. The “signaling endosome hypothesis” involves the 
internalization of neurotrophin/receptor complex from cell membrane, the formation of 
specialized endosomes containing these and other specific molecules, and the subsequent 
transport of these organelles towards the neuronal soma where the signal will be delivered 35. 
Interestingly, in 2006 Markevich and colleagues proposed a new mechanism of signal propagation 
that does not require internalization nor of NGF or TrkA37. This study was motivated by the 
demonstration that local administration of radio-iodinated NGF to the axonal terminal of neurons, 
was capable of inducing tyrosine phosphorylation in cell bodies at least 30 min before the first 
detection of NGF arriving from distal axon portion38. This group proposed that signals can be 
transmitted by a wave of protein phosphorylation and de-phosphorylation of protein kinases, 
which would create a delicate balance by increasing the availability of these molecules to act. The 
“bi-stable” circuit created, can propagate the signal with high-speed (hundreds of µm/s) and for 
long distances.  
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Although several models have been proposed, sometimes discordant, it seems likely that the cell 
uses more than one mechanism. However, the strongest experimental evidences are in favor of 
the “signaling endosome hypothesis”.  
1.6. The “signaling endosome hypothesis” 
Endocytosis is a basic biological mechanism, by which the cell internalizes nutrients and molecules 
present on the outside, or adjusts the composition of the membrane. But an explosive growth in 
knowledge has given a new dimension to our understanding of this process. For various reasons, 
endocytosis is now considered as an integral part of the signaling circuit of cell. For example, the 
variation of the number and the type of molecules such as the receptors on the cell membrane 
allows the modulation of different metabolic pathways. This control mechanism occurs not only in 
time but also in space, the localization of specific molecules in discrete districts is an example of 
this property39. Endosomes possess many useful characteristics for the purpose of modulation of 
the signal. Through these organelles, in fact, the cell can control the biochemical processes that 
could not take place on the cell membrane, for example by adjusting the endosomal pH. Also the 
small volume of the endosomes facilitates multiple interactions, and the regulation of protein and 
lipid composition of these compartments, as well as their fast transport through the microtubules 
constitute a highly efficient system for intra- and inter-cellular communication39.  
The first step in the endocytic process of growth factors receptors is their internalization. Broadly, 
this can be of two types: Clathrin-mediated and non-Clathrin-mediated. The latter includes many 
phenomena of a different nature (internalization via caveolae, Pincher-mediated macropinocytosis 
etc) and poorly characterized in molecular detail40.  
In Clathrin dependent endocytosis, the most extensively characterized route, ligand binding 
accelerates the recruitment of receptors to Clathrin-coated pits through adaptors, such as AP-2 or 
β-arrestins1. Clathrin then polymerizes, and this drives the invagination of the pit, which is 
eventually released into the cytoplasm through the action of the GTPase dynamin139. After 
internalization, by either clathrin-mediated endocytosis or non-clathrin-mediated endocytosis, 
receptors are fused to early endosomes. Trafficking in the endosomal compartment is controlled 
by several Rab proteins (small GTP-binding proteins of the Ras superfamily). Each GTP-bound Rab 
protein resides in a particular type of endosome and functions by recruiting specific effector 
proteins in an orderly and sequential manner. Following their internalization into early Rab5-
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containing endosomes, receptors can rapidly recycle back to the plasma membrane by a Rab4-
dependent mechanism, traffic to the recycling compartment that contains Rab11A or remain in 
endosomes, which mature into multivesicular bodies (MVBs) and late endosomes. MVBs are 
defined by the presence of intraluminal vesicles (ILVs) that are formed in a process of inward 
membrane invagination involving ESCRT (endosomal sorting complex required for transport) 
complexes. Early-to-late endosome maturation involves the acquisition of Rab7 and the removal 
of endosomal components that are capable of, and necessary for, recycling. In the MVBs, cargo 
destined for degradation is incorporated into ILVs. Fusion of late endosomes and MVBs with 
lysosomes carrying proteolytic enzymes results in cargo degradation41.  
 
Figure 7. Endocytosis. Endocytic vesicles derived from both clathrin-dependent and clathrin-
independent endocytosis fuse with early endosomes. Endosomal trafficking is controlled by 
several Rab proteins. Each GTP-bound Rab protein resides in a particular type of endosome and 
functions by recruiting specific effector proteins. Following their internalization into early RAB5-
containing endosomes, receptors can rapidly recycle back to the plasma membrane by a RAB4-
dependent mechanism, traffic to the recycling compartment that contains RAB11A or remain in 
endosomes, which mature into multivesicular bodies (MVBs) and late endosomes. Early-to-late 
endosome maturation involves the acquisition of RAB7. Fusion of late endosomes and MVBs with 
lysosomes results in cargo degradation (figure taken from Sorkin and Zastrow 2009)41. 
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Similar to most other receptor-mediated endocytic pathways, neurotrophins bind to and activate 
Trk receptors at the surface, which, in turn, triggers its internalization into early endosomes. The 
complex is then sorted either into recycling endosomes to return back to the cell surface, or it is 
transported retrogradely to the cell body to deliver its signal, in this path occurs the maturation 
from early endosomes to late endosomes, then into multivesicular bodies (MVBs) that finally fuse 
with lysosomes. Therefore, each of these different subcellular organelles( ranging from 50 to 220 
nm in diameter) has been found to contain internalized NGF using different approaches and 
experimental systems35.  
Signaling endosomes move inside the neuron using the system of microtubules. This type of 
transport is driven by two main families of molecular motors, kinesins and dynein, which carry 
their cargoes in opposite directions. Kinesins are mainly anterograde motors and move towards 
the plus-end of microtubules (axonal tip), whereas dynein progresses retrogradely towards their 
minus end (cell soma)42.  
However, neurotrophins do not act only through retrograde axonal transport. In fact, the 
activation of NGF/TrkA complex in the cell soma or on the axonal tip, produces different cellular 
responses. Endocytosis and retrograde transport of NGF-TrkA were necessary for activation of 
Erk5 and phosphorylation of CREB in the nucleus. By contrast, activation of TrkA by NGF binding in 
the soma resulted in the activation of Erk1 and Erk2, which was not sufficient for the 
phosphorylation of CREB and for induction of survival signaling41. Moreover, although NGF and NT-
3 have different affinities for TrkA, they both phosphorylate surface TrkA to a similar extent. These 
neurotrophins also act together to support the development of sympathetic neurons by activating 
TrkA-dependent axonal outgrowth. However, only NGF is able to promote the axonal retrograde 
transport of TrkA-containing endosomes that lead to survival40. It was further demonstrated that 
retrograde transport of signaling molecules downstream of phosphorylated TrkA, but not 
phosphorylated TrkA itself, also support neuronal survival. Nevertheless, the finding that 
retrograde transport of neither NGF nor phosphorylated TrkA is required to convey a survival 
signal is intriguing. These mechanisms may exist to complement the NGF/TrkA signaling endosome 
hypothesis35.  
Despite extensive research, the identity of "signaling endosome" remains unknown. It has been 
shown that the NGF-TrkA complex resides in clathrin-coated-vesicles, together with components 
of the signaling such as: Erk1/2, PI3K and PLCγ. Also, activated phosphoTrkA is contained in 
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endosomes positive for Rab5 and EEA1 (early endosome antigen 1, a marker of early endosomes) 
in PC12 cells35. Moreover, in this same cell type, the administration of NGF inhibits the maturation 
of early endosomes (Rab5 positive) in late endosomes (Rab7 positive), through the GTPase 
Rab5GAP activity, thereby increasing the signaling of TrkA43.  
As it regards neurotrophic receptor, p75NTR is believed to be recycled back to the plasma 
membrane, since no degradation has been observed in motor neurons as late as three hours after 
stimulation with NGF, confirming early results obtained in PC12 cells. In contrast, TrkA has been 
found to mainly follow the degradative route, even though a pool of the receptor is sorted to the 
recycling pathway. Interestingly, p75NTR has been shown to modulate NGF-induced TrkA 
internalisation, and a population of vesicles positive for both TrkA and p75NTR was found in NGF-
stimulated PC12 cells. Such a p75NTR/TrkA double positive organelles could then either be 
considered early endosomes, as well-known signalling platform, or recycling endosomes42. 
Late endosomes marked by Rab7 have also been implicated in regulating TrkA signaling and axonal 
transport of neurotrophin signals. Kruttgen and colleagues found that following NGF treatment, 
TrkA co-immunoprecipitated with Rab7 in PC12 cells. Expression of a dominant-negative Rab7 
mutant resulted in endosomal accumulation of TrkA and pronounced enhancement of TrkA 
signaling in response to limited stimulations with NGF. In addition, activation of Erk1/2 was 
increased, and neurite outgrowth was enhanced in these cells35. An alternative model was 
proposed on the basis of the detection of the late endosomal marker Rab7 in retrograde carriers 
isolated from mouse motor neurons. This study suggested that retrograde transport requires the 
replacement of Rab5 by Rab7 on the endosomal membrane and that retrograde carriers are a pool 
of late endosomes41. 
However, many aspects of this type of signaling are still unclear. For example, it is unclear whether 
a specific population of endosomes delivers a specific signal, also how these organelles avoid 
lysosomal degradation and how they can terminate or amplify their signal is not known. 
Regarding proNGF, the scientific literature lacks studies of its intracellular trafficking and its 
interactions. This is mainly due to two reasons: the recent discovery of its specific actions and the 
lack of labeling methods suitable for the study of proNGF movements within the cell. The first 
study on the trafficking of both precursor and mature NGF was conducted by De Nadai and 
colleagues. It was shown that in DRG neurons, proNGF administered on the axon terminal is 
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transported in a retrograde manner towards the neuronal soma. Also a small part of the 
population of retrograde moving vesicles containing NGF (about 9%) is transported from the 
soma, back to the axon terminal through anterograde transport44.  
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2. Purpose of the thesis 
My thesis work is part of a project already in progress, aimed at creating a tool for the study of 
intracellular trafficking and molecular interactions of neurotrophins. In particular, my study can be 
divided into two main parts:  
 production and purification of fluorescent neurotrophins: fluoproNGF and fluoNGF  
 characterization of the similarities and differences in interactions with protein partners 
involved in their internalization and function.  
2.1. Experimental approach 
At the start of my thesis, the plasmid containing the tagged neurotrophin had already been 
obtained. E. coli BL21 strain was transformed with plasmid and left to grow, protein expression 
was subsequently induced. The proNGF contained in inclusion bodies was collected, refolded and 
purified by ion-exchange fast protein liquid chromatography (FPLC). Purified precursor 
neurotrophin was then digested by trypsin and further purified by ion exchange FPLC in order to 
obtain mature NGFybbR. 
 
Figure 8. Schematization of different steps in proNGFybbR and NGFybbR synthesis and 
purification process. 
The purified tagged neurotrophins are conjugated via in vitro enzymatic reaction to the substrate 
CoA-Alexa647, making them suitable for cell imaging experiments. The reaction mix is then 
purified by HPLC in order to separate the fluorescent protein from the population that has not 
reacted. The functionality of the fluoproNGF and of the fluoNGF was then verified via microarray 
analysis. The neurotrophins were individually administered to differentiated PC12 cells. 
Subsequent immunocytochemistry experiments and confocal microscopy imaging have allowed to 
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analyze the colocalization of neurotrophins with protein partners such as TrkA, p75, Sortilin, 
Rab11, Rab7, Rab5 and EEA1. The neurotrophic receptors were chosen by virtue of their direct 
involvement in the signaling of NGF and proNGF. As it regards the endosomal partners, the greater 
or lesser percentage of colocalization would indicate that NGF or proNGF are preferentially 
associated with endosomes belonging to a certain endosomal pathway rather than to another. In 
particular Rab11 identifies the recycling endosomes, Rab7 identifies the late endosomes destined 
to the degradative pathway, Rab5 identifies the newly formed endosomes (early endosomes) 
while EEA1 is characteristic of endosomes that carry signal. The collected data were analyzed with 
a homemade Matlab script and allowed to characterize the different molecular interactions of 
both precursor and mature NGF. 
 
3. Materials and methods: 
3.1. proNGFybbR and NGFybbR expression, purification and 
refolding 
Protein expression 
For the production of tagged neurotrophins, the protocol described in Rattenholl et al. 200145 was 
adapted and used. The protocol allows for the purification of recombinant proNGF from inclusion 
bodies of E. coli. 
Briefly, the human proNGF coding sequence (UniProtKB-P01138) was inserted in a pET11a 
prokaryotic expression vector (Novagen), and used as a template for insertional mutagenesis. The 
ybbR tag coding sequence was inserted into the C-terminus of proNGF cDNA. The expression was 
guided by T7 promoter and induced by IPTG (Isopropil-β-D-1-tiogalattopiranoside). E. coli BL21 
strain was transformed with 100 ng of plasmid. The cells were plated on agar plates containing 
Luria Bertani (LB) medium supplemented with ampicillin, and grown overnight at 37°C.  
The day after, one colony was picked and inoculated in 20 ml of LB medium supplemented with 
ampicillin and grown overnight at 37°C with shaking at 250 rpm. Then, 18 ml of this culture were 
inoculated in 1 liter of LB medium supplemented with ampicillin, divided into five flasks and 
allowed to growth until an OD600nm of about 1 was reached, before inducing protein expression 
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with 1 mM of IPTG for 5 hours. A small portion of not-induced culture was conserved as a control. 
Small aliquots from induced cultures were also collected. 
Purification of inclusion bodies 
Cells were then centrifuged at 6000 rpm, 4°C for 10 minutes. The obtained pellets were 
resuspended in 20 ml of lysis buffer (10 mM Tris-HCl pH 8,1 mM EDTA pH 8 and 1 mg/ml lysozyme) 
and allowed to stand for 1 hour at room temperature. This solution was sonicated three times 
(45’’ ON, 60’’ OFF at 4°C) and finally DNAse was added (50 µg/ml) supplemented by MgCl2 (5 mM). 
After 30 minutes, 10 ml of Triton buffer was added, consisting of 20 mM EDTA, 0,5 M NaCl and 2% 
v/v TRITON X-100 (Sigma Aldrich).  
The solution was then transferred into two glass centrifuge tube (Corex) and centrifuged at 13.000 
rpm, 4 °C for 30 minutes. The supernatant was discarded, and the pellet was resuspended in 20 ml 
of buffer containing:  10 mM Tris-HCl pH 8 and 1 mM EDTA. At this point 10 ml of Triton buffer 
was added to the solution, followed by centrifugation at 13.000 rpm, 4°C for 30 minutes. The 
pellet was washed and harvested three times in this condition using 25 ml of buffer containing: 50 
mM Tris-HCl pH 7,5 and 1 mM EDTA. Each step of the process was controlled by SDS-PAGE. 
Protein refolding 
To allow proper refolding of the neurotrophin, the obtained pellet was solubilized in Guanidinium 
buffer (6M Guanidinium ; 100 mM TrisHCl pH 8; 1mM EDTA; 100 mM DTT). Then hydrochloric acid 
was added until the solution reached pH 3,5. At this point the solution was centrifuged at 13.000 
rpm, 4°C for 30 minutes. The supernatant, containing the protein of interest, was dialyzed in 300 
ml of Guanidinium buffer for 36 hours, changing the buffer every 12 hours.  
After dialysis, protein concentration was misured and 5 mg of neurotrophin was added every hour 
to 100 ml of refolding buffer (1M Arginine pH 9,3; 100 mM Tris-HCl pH 9,3; 5 mM EDTA pH 8; 5 
mM GSSG and 5 mM GSH). After completing the refolding step, the buffer has been changed by 
dialysis with one containing 50 mM H2NaPO4 pH 7 and 1 mM EDTA.  
 
3.2. Neurotrophins purification 
Fast protein liquid chromatography 
Fast protein liquid chromatography (FPLC), is a form of liquid chromatography that is often used to 
analyze or purify mixtures of proteins. As in other forms of chromatography, separation is possible 
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because the different components of a mixture have different affinities for two materials, a 
moving fluid (the “mobile phase”) and a porous solid (the “stationary phase”). The mobile phase is 
an aqueous solution also called "buffer", the composition of which can be varied by drawing fluids 
in different proportions from two or more external reservoirs. The mobile phase flowing through 
the stationary phase, constituted by a plastic or glass cylinder containing a resin composed of 
beads, usually cross-linked agarose. FPLC resins are available in a wide range of bead sizes and 
surface ligands depending on the application. Ion exchange is a common FPLC strategy. This 
technique separates proteins by their net charge, which depends on the composition of the 
solution containing them. Generally, proteins are amphoteric molecule, possessing either 
positively and negatively charged residues when dissolved in a solution which possesses specific 
pH. Overall at a specific pH value, the surface of a protein has a net charge that depends on the 
number and identities of these amino acids groups.  When the positive and negative charges are 
equal in number, and the net charge on the protein is zero, this latter is considered to be at its 
isoelectric point (pI). So by modulating the pH of the mobile phase it is possible to regulate the net 
charge of the protein of interest for our purposes. In ion exchange chromatography, proteins 
flowing through a mobile phase bind bead ligands which possess opposite charge. Then, the 
protein can be eluted again in mobile phase by, for example, increasing the ionic strength of the 
solution. This can be achieved by gradually substituting a buffer, for example “A”, with a buffer “B” 
which possesses major ionic strength (e.g. elevated concentration of NaCl). High salt 
concentrations cause shielding of the charged groups on the protein surface and effective binding 
to ion exchanger can no longer take place. In particular, in this work it was adopted the cation 
exchange FPLC. proNGF and NGF are very basic proteins, possessing pI of about 9. So, in mobile 
phase having pH of 7,4 this proteins show net positively charge. The chosen solid phase matrix 
possesses negatively charged sulphonate groups, able to bind our proteins. Buffer A have a 
modest amount of salt (100 mM HNa2PO4), which prevents aggregation of neurotrophins, while 
buffer B contains both phosphate salt (100 mM HNa2PO4) and a high concentration of NaCl (1M). 
Increasing the proportion of buffer B with respect to A (from 0% to 100%) allow the elution of the 
sample, which it will be detected by the instrument via measuring the absorbance at 280 nm. 
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proNGFybbR 
To obtain a pure solution of proNGFybbR, the refolded neurotrophin was purified by ion-exchange 
FPLC, using the following mobile phase buffer: A) 50 mM H2NaPO4, 50 mM HNa2PO4 pH 7,4; B) 50 
mM H2NaPO4, 50 mM H2NaPO4 and 1M NaCl pH 7,4. proNGFybbR was collected by linear gradient 
(from 0% to 100% of buffer B) using 1ml/min of mobile phase flux. Fractions of 3 ml were 
harvested. A small aliquot (20 µl) of each fraction was assayed by SDS-PAGE.  
Fractions from 48 to 53 were joined and dialyzed overnight in a buffer containing 50 mM H2NaPO4 
pH 7 and 150 mM NaCl (storage buffer), and finally aliquoted.  To ascertain the integrity of the 
purified neurotrophin, 100 µg of protein was analyzed by mass spectrometry (MS). MS analysis 
was performed by an external facility (Toscana Life Sciences Foundation).  
NGFybbR 
Mature neurotrophin was obtained by controlled proteolysis of the purified proNGFybbR, using 
trypsin protease (1 µg of enzyme for 300 µg of neurotrophin, 16 hours at 4°C). 14 ml of 
proNGFybbR was digested and then diluted in 100 ml of FPLC buffer A. Another step of FPLC 
chromatography was used for the purification of mature NGFybbR. Also in this case, 20 µl of each 
collected fraction were analyzed by SDS-PAGE. Small amounts (100 µg each) from three different 
fractions were analyzed by Mass spectrometry. 
The obtained fractions of NGFybbR were joined in this way: from fraction 32 to 39 (1° peak), from 
42 to 50 (2° peak) and from 52 to 62 (3° peak). The three samples were dialyzed overnight in the 
storage buffer and subsequently aliquoted.  
3.3. fluoproNGF and fluoNGF production 
The method of labeling used in this project is derived from a work of Yin and colleagues46. It is 
based on the insertion of a DNA sequence within the cDNA encoding our protein of interest. This 
sequence codes for an 11 amino-acid long peptide, called ybbR, obtained via directed-evolution 
shortening process of ybbR ORF, in order to identify new shorter substrates of the enzyme Sfp 
synthase from Bacillus subtilis. In nature, this enzyme is responsible for the post-translational 
modification of certain proteins such as peptide carrier proteins and acyl carrier protein. The 
reaction involves the transfer of the 4’-phospho-Pantetheinyl (Ppant) group of CoenzymeA onto a 
conserved serine residue. Sfp synthase has been found to display impressive substrate promiscuity 
toward the small-molecule entities covalently conjugated to CoA through the terminal thiol.  This 
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property can been used to fuse the Ppant group to a Fluorophore, in order to visualize proteins in 
live cells. 
 
Figure 9. Site-specific labeling mediated by Sfp synthase.  
Site-specific labeling of proNGFybbR and NGFybbR 
For the fluorolabeling reaction of proNGFybbR, 85 µg of neurotrophin were incubated for 30 
minutes at 37°C and 350 rpm in a reaction mix composed by: 76 µM CoA-Alexa647, 4,8 µM Sfp 
Synthase (New England Biolabs), 38 mM MgCl2, in phosphate buffer ( #D8662 Sigma Aldrich) up to 
260 µl final volume. 
For the fluorolabeling of NGFybbR, 90 µg of neurotrophin were incubated in the same conditions 
of the proNGFybbR in buffer containing: 73 µM CoA-Alexa647, 17 µM Sfp Synthase, 36 mM MgCl2, 
in phosphate buffer up to 270 µl final volume. 
CoA-Alexa647 substrate was synthesized starting from: 200 nmol of Alexa647 maleimide (Thermo 
Fisher Scientific) and 260 nmol of Coenzyme A trilithium salt (Sigma-Aldrich) dissolved in 20 mM 
HEPES (Sigma-Aldrich) pH 7,2 up to a final volume of 240 µl. The solution was stirred for 4 hours at 
350 rpm and 37°C, it was then purified by Reverse Phase HPLC using Phenomenex Fusion-RP phase 
column and 10 mM ammonium formate/acetonitrile as mobile phase. 
3.4. High-performance liquid chromatography  
High-performance liquid chromatography (HPLC) is another chromatographic technique suitable 
for separating protein mixtures. Differently from the FPLC, HPLC column require a higher pressure 
to operate, also the volume of sample analyzed is smaller. As described above, in this work it was 
used the same separating principle as with FPLC (cation exchange HPLC). Furthermore, the HPLC 
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system used possesses a detector able to measures the fluorescence at 633 nm, which has 
allowed the identification and separation of fluorescent neurotrophins from those not reacted. 
HPLC purification 
In order to separate the fluorescent neurotrophins from those non-reacted, the reaction mix was 
processed by cation exchange HPLC, using Propac SCX-20 column (Dionex, Thermo Fisher 
Scientific) and 100 mM HNa2PO4 mobile phase with 0M to 1M NaCl gradient.  
3.5. SDS-PAGE 
Polyacrylamide gel electrophoresis is a common biochemical technique, used to separate 
biological macromolecules such as proteins and nucleic acids, according to their electrophoretic 
mobility. This latter is a function of the length, conformation and charge of the molecule. The 
protein mixture is passed through a molecular sieve (gel), thanks to the flow of ions generated by 
applying an electric current to the buffer in which it is immersed. There are various types of this 
technique, in this work SDS-PAGE was used, that is Polyacrylamide gel electrophoresis in the 
presence of sodium dodecyl sulfate. SDS is an anionic detergent able to denature proteins and 
make them negatively charged in a uniform manner. In this way the electrophoretic mobility of a 
protein is determined only by molecular weight.  
The used polyacrylamide gel is constituted by these components:  
Running gel 
  20 ml of  Acrylamide/Bis Solution 30%, 29:1 (#1610156 Bio-Rad); 10 ml Tris-HCl 1,5M pH 
8,8; 0,4 ml SDS 10% (w/v); 0,4 ml Ammonium Persulfate 10% (Sigma Aldrich); 16 µl 
N,N,N′,N′-Tetramethylethylenediamine (TEMED); 9,2 ml deionized water. 
Stacking gel 
 3,4 ml of  Acrylamide/Bis Solution 30%, 29:1 (#1610156 Bio-Rad); 2,5 ml Tris-HCl 1M pH 
6,8; 0,2 ml SDS 10% (w/v); 0,2 ml Ammonium Persulfate 10% (Sigma Aldrich); 20 µl 
N,N,N′,N′-Tetramethylethylenediamine (TEMED); 13,6 ml deionized water. 
Standard Electrophoresis apparatus was used (Bio-Rad). The components of the running gel were 
mixed and added to the glass support. After 30 minutes, the running gel has completed the 
polymerization, so the stacking gel solution was added and allowed to polymerize for another 30 
 26 
 
minutes. For the preparation of sample, the protein solution was mixed with SDS-sample buffer 
(50 mM Tris-HCl pH6,8; 100 mM dithiothreitol, 2% (w/v) SDS; 0,1% bromophenol blue; 10% (v/v) 
glycerol) in the 1:1 ratio. Then the sample was heated at 95°C for 10 minutes and loaded on gel. 
Tris/Glycine/SDS (#1610732 Bio-Rad) buffer was used according to the manufacturer. 
Electrophoresis was performed using 90 Volt of power supply. Finally, the proteins were stained 
using Coomassie Brilliant Blue R-250 solution (45% methanol, 10% glacial acetic acid, 45% water, 3 
g/L Coomassie Brilliant Blue R-250). 
3.6. Cell culture and differentiation 
For neurodegeneration studies, one of the most used and cited culture systems has been the PC12 
cell line which was derived from a transplantable rat pheochromocytoma. These cells express all 
the three principal receptors involved in the signaling of the neurotrophins: TrkA, p75 and Sortilin. 
A notable feature of PC12 cells is that they respond to nerve growth factor (NGF). In response to 
NGF, PC12 cells are converted from proliferating chromaffin-like cells to nondividing sympathetic-
neuron-like cells that extend axons and become electrically excitable. This remarkable property 
has drawn considerable attention, and these cells are widely used to study neurotrophin signal 
transduction and neuronal differentiation mechanisms47. 
PC12 cells (ATCC, CRL-1721) were maintained at 37°C, 5% CO2 in RPMI 1640 GlutaMAX medium 
(Thermo Fisher Scientific) supplemented with 10% horse serum, 5% fetal bovine serum and 1%  
penicillin/streptomycin from Gibco (complete medium).  
To induce differentiation, the cells were first subjected to a priming process, which consists of a 
mild differentiation, then a second step of differentiation was carried out, that allows to complete 
the process. For priming, the cells were cultured in complete medium supplemented with 15 
ng/ml of wt recombinant human NGF for six days, 70% of the medium was renewed every two 
days. 
After six days of priming, cells were harvested, the medium was replaced with one containing: 
RPMI 1640 GlutaMAX supplemented with 1% horse serum, 0,5% fetal bovine serum, 1%  
penicillin/streptomycin and 50 ng/ml of wt recombinant human NGF (differentiation medium). 
Cells were plated on 8 well Glass micro-Slide (Ibidi) microscope slides, at 20.000 cells/cm2 density. 
All medium was renewed after 48 hours. Four days of differentiation are necessary to complete 
the process.  
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3.7. Immunocytochemistry 
Immunocytochemistry (ICC) is a common laboratory technique used to anatomically visualize the 
localization of a specific protein or antigen in cells by use of a specific primary antibody that binds 
to it. The primary antibody allows visualization of the protein under a fluorescence microscope 
when it is bound by a secondary antibody that has a fluorophore conjugated. The process 
comprises cultivation of cells on support such as microscope slides. These are then treated with a 
solution containing paraformaldehyde, capable of cross-linking many species of molecules 
between them and thus to keep the sample in the desired state (fixing). At this point, the cells are 
permeabilized with a detergent, for example saponin, and treated with a blocking solution 
containing bovine serum albumin (BSA) directed to "occupy" the reactive chemical groups, so as to 
reduce any nonspecific binding of the antibody . The subsequent administration of antibodies 
directed against the protein of interest will allow their visualization. 
At the end of the differentiation process, cells medium was replaced with sterile phosphate buffer 
with Calcium and Magnesium (#D8662 Sigma Aldrich) in order to wash out the residual wtNGF. 
After one hour, the medium was replaced with differentiation medium containing fluoproNGF 
(200 ng/ml) or fluoNGF (100 ng/ml) instead of wtNGF. After administering the fluo-neurotrophins 
for different time duration (1, 2 and 3 hours), cells were fixed using 4% paraformaldehyde, 4% 
sucrose in phosphate buffer, for 15 minutes. Cells were then permeabilized in phosphate buffer 
containing 8% of Bovine Serum Albumin (Sigma Aldrich) and 0,1% Saponin (Sigma Aldrich), for 7 
minutes. After five washes in phosphate buffer supplemented with 8% BSA, cells were blocked 
using the same solution for 1 hour. The primary antibodies were administered for 16 hours at 4°C, 
diluted in blocking solution. In particular: 1:100 of Anti-TrkA #06-574 Millipore, 1:100 of Anti-P75 
#07-476 Millipore, 1:100 Anti-Sortilin #ANT-009 Alomone Labs, 1:200 Anti-Rab11 Cell Signaling 
#5589, 1:200 Anti-Rab7 Cell Signaling #9367, 1:300 Anti-Rab5 Cell Signaling #3547, 1:200 Anti-
EEA1 Cell Signaling #3288. The secondary antibody (1:500 of Anti-Rabbit conjugate with Alexa488 
fluorophore) was administered for 2 hours at room temperature. The cells were washed three 
times with phosphate buffer and once with Milli-Q water (Millipore). At the end, the slide was 
covered with Fluoroshield with DAPI (Sigma Aldrich).  
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3.8. Microscopy Measurements 
Confocal microscopy 
Laser scanning confocal microscopy (LSCM) is a widespread technique in fluorescence microscopy. 
In LSCM it is possible to selectively collect fluorescence from a desired focal plane that is (~0.6-1 
µm thick), while in wide-field microscopy the measured fluorescence comes from the entire 
thickness of the sample. Basically, a light source excites the fluorescent molecules that emit 
photons to a longer wavelength detectable by the instrument. In particular, rather than exciting 
the entire field at once, a laser beam passes through a dichroic mirror and then is focused by an 
objective lens into a small (ideally diffraction limited) focal volume within or on the surface of a 
specimen. As only one point in the sample is illuminated at a time, 2D or 3D imaging requires 
scanning over a regular raster in the specimen. Reflected laser light as well as any fluorescent light 
from the illuminated spot passes back through the objective lens and finally reaches a pinhole that 
allows the passage of only the reflected light coming from the selected focal plane. After passing 
the pinhole, the light intensity is detected by a photo-detection device (usually a photomultiplier 
tube (PMT)), transforming the light signal into an electrical one that is recorded by a computer. 
Finally, using two fluorophores with distinct excitation and emission spectra, it is possible to 
discriminate the signal of two proteins of interest. 
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Figure 10. Schematic picture representing the basic principle of confocal microscopy. The dotted 
green line represents the reflected light of the selected focal plane. The red dotted line represents 
the reflected light coming from a different focal plane. 
All experiments were conducted using a confocal laser scanning microscope (Leica TCS SP5 SMD), 
equipped with 63X/1,2 NA objective.  
Acquisition settings 
For colocalization analysis, two solid state lasers were used: one with a wavelength of 488 nm, and 
the other of 633 nm. The excitation of the two channels has been applied sequentially. 1 Airy unit 
pinhole was adopted. The images were acquired by maintaining a pixel size of approximately 90 
nm, in order to have an adequate spatial resolution to detect endosomes (average diameter 200 
nm). 
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Image analysis 
Colocalization analysis was performed by custom made Matlab scripts.  The quantitative imaging 
analysis used is the Manders colocalization coefficient48. In particular, each image has two 
fluorescence signals R (red) and G (green), belonging to two different proteins. Manders 
colocalization coefficient represent the percentage of co-occurrence of a signal with respect to 
another. For a given signal R, this coefficient is calculated as:  
   
         
    
 
Where Ricoloc represents the fluorescence intensity of the signal R which co-localizes with the signal 
G and Ri represents the fluorescence intensity of all R signal.  
The software has been tested by analyzing the colocalization of two signals present on standard 
slides for the alignment of the laser. These slides contain beads of different sizes (100nm, 200nm, 
500nm ecc.), each of these possesses different fluorophores excitable at different wavelengths. 
These slides should then provide a theoretical M1 coefficient equal to 1.  
Over 100 images were analyzed by visual inspection; the data were compared with the software 
counterpart, in this way the accuracy of the software was validated. Finally, each image analyzed 
by the software was controlled manually, and eventually discarded.  
Statistical analysis 
Statistical analysis of data was performed using OriginLab software. The differences in the 
colocalization percentage between the populations during the three times of incubation of 
fluorescent neurotrophin were analyzed by ANOVA. The differences in the colocalization 
percentage between NGF and proNGF with endosomal partners were analyzed by two-tailed 
Student's t-test. For all the analysis it was adopted α=0,05 as a level of significance. 
3.9. Microarrays 
A DNA microarray (also commonly known as DNA chip) is a collection of microscopic DNA spots 
attached to a solid surface such as glass or silica slide. DNA microarrays allow to measure the 
expression levels of large numbers of genes simultaneously or to genotype multiple regions of a 
genome. Each DNA spot contains milions of a specific DNA sequence, known as probes (or 
reporters or oligos). These can be a short section of a gene or other DNA element that are used to 
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hybridize a cDNA or cRNA (also called anti-sense RNA) sample (called target) under high-stringency 
conditions. Probe-target hybridization is usually detected and quantified by detection of 
fluorophore- or chemiluminescence-labeled targets to determine relative abundance of nucleic 
acid sequences in the target.  
There are many types of microarrays, divided according to the type and method of synthesis of the 
probes that contain, and also according to the experimental approach chosen. In this work it was 
used a solid-phase microarray from Agilent Technologies. This is an oligonucleotide (60-mer) 
microarray, consisting of 60.000 spots of DNA (features), each of which contains thousands of 
identical and specific probes attached to a solid surface. Probes are synthesized by ink-jet printing 
technologies. It is commonly used for “Gene expression profiling” analysis, exploiting a single-
channel microarrays approach. Contrary to the two-channel microarrays, in which the level of 
gene expression is compared simultaneously between two samples using the competitive 
hybridization between these, in one-channel microarray each sample was analyzed independently 
and the data are then normalized.  
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Figure 11. Schematic representation of gene-expression study process via microarray analysis. 
Gene expression experiments 
To verify the functionality of both fluo-NGF and fluo-proNGF, we analyzed the gene expression 
profile induced by fluo-neurotrophins in PC12 cells, comparing it with that of wild type 
neurotrophins. PC12 cells were treated with each neurotrophin specie individually (25 ng/ml for 
NGF and 50 ng/ml for proNGF) for one hour. Then cells were harvested and RNA isolated using 
TRIzol  (Life Technologies) following the standard protocol. RNA was purified using Qiagen RNeasy 
Mini Kit and the quality assessed by the Bioanalyzer using the 6000 nanoKit (Agilent Technologies). 
The RNA was then labelled, purified and hybridized using Sure Print G3 Rat Gene Expression v2 
8x60K Microarray Kit and One-Color Microarray standard Agilent protocol (version 6.8, June 2015). 
After washing, chips were scanned using Agilent G2564C scanner with laser resolution of 3 
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micrometres. Expression data were extracted from TIFF images using Agilent Feature extraction 
software v 10.7.3.1. Filtering, normalization and further analysis of data have been performed 
using R-Bioconductor. Data were normalized to the 75th percentile in Log2 scale. Differential 
mRNAs were selected by the R-Limma package: differentially expressed mRNAs are those with 
absolute values of Log2 Fold Change ratio> 1.0 and Limma P-value <0.0512. Hierarchical clustering 
of samples was computed by R-hclust package. Principal Component Analisis (PCA) was obtained 
by the R-prcomp package. 
 
3.10. Quantification of fluoproNGF intracellular cleavage process  
To measure the fluoproNGF cleavage process during the time window of our experiments, PC12 
cells were grown and allowed to differentiate in 6-well plate (1,58 cm2 for each well). After 
differentiation, fluoproNGF (50 ng/ml) was administered for different times. After administration, 
cells were washed with phosphate buffer and lysed in 100 µl of RIPA buffer (#R0278 Sigma Aldrich) 
supplemented with proteases inhibitors (cOmplete Mini easy pack Roche) and phosphatases 
inhibitors (Roche). Equal amounts of lysed sample (37 µl) were loaded on a gel for SDS-PAGE. The 
gel was imaged using an Image Quant LAS4000 (GE Healthcare) gel-imager equipped with a Led 
lamp and a detector for measuring the fluorescence of the Alexa647. 
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4. Results 
4.1. Neurotrophins production 
At the start of my thesis, the plasmid containing the tagged neurotrophin had already been 
obtained. The tag was inserted through an insertional mutagenesis method into the C-terminus of 
Human proNGF coding sequence. This latter was chosen as the best site to insert the tag, because 
it does not interact with TrkA nor p75. Human proNGF cDNA was cloned in pET11 bacterial vector 
and was used as template. The cDNA coding sequences of ybbR (DSLEFIASKLA) tag was inserted at 
the C-terminus of proNGF. 
 
Figure 12. Schematic representation of a pET prokaryotic expression vector. Ori is the origin of 
replication of the plasmid. lacI is the gene encoding the lactose repressor. P T7 is the T7 promoter 
and lacO is the lac operator. MCS is the multiple cloning site where the cDNA sequence was 
inserted and the transcription of this gene ends thanks to the transcription terminator element. 
Finally, ampR is the gene ensuring the antibiotic resistance.  
 
Briefly, regarding the whole process of production of tagged neurotrophins, the protocol 
described in Rattenholl et al. 200145 was adapted and used. The Protocol provides for the 
purification of recombinant proNGF from inclusion bodies. E. coli BL21 strain was transformed 
with plasmid and left to grow, then the culture was splitted into five flasks and amplified, finally 
protein expression was induced. Cells were then lysed and sonicated. Subsequential cycles of 
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centrifugation and resuspension in appropriate buffers allowed the purification of inclusion bodies 
containing the unfolded proNGFybbR. Each steps of the process were controlled by SDS-PAGE. 
 
Figure 13. SDS-PAGE (15% poly acrylamide) analysis of proNGFybbR expression. Mw is standard 
molecular weights marker. Cell culture analysis before induction (N.I.) and after induction (I.1-5), 
the S. and P. lanes represent protein content of supernatant and pellet of cell lysate after 
sonication. The content of purified inclusion bodies is shown (I.B.). The significant band of about 
26 kDa of molecular weight in induced, pellet and inclusion bodies lanes identify the proNGFybbR. 
 
The protein was then refolded and dialyzed. In order to obtain a pure solution of proNGFybbR, the 
sample was further purified by ion-exchange FPLC. The fractions containing the protein (from 48 
to 53) were harvested. 
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Figure 14. Chromatographic profile of proNGFybbR purification. In the Y axis the measured 
absorbance at 280 nm is reported, while the X axis shows the flow of the mobile phase during the 
chromatographic run. Numbers in red represent the fractions.  
 
A small aliquot of each collected fraction was assayed by SDS-PAGE.  
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Figure 15. SDS-PAGE analysis of FPLC fraction. Mw lane is standard molecular weights. The 
different numbers in each lane represent the corresponding FPLC fractions. Numbers in red 
represent the fractions harvested. 
 
Fractions from 48 to 53 were pooled and dialyzed in storage buffer that allows the proper 
conservation of protein, and finally aliquoted. To ascertain the integrity of the purified 
neurotrophin, 100 µg of protein were analyzed by mass spectrometry. The analysis result is shown 
in figure. 
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Figure 16. Mass spectrometry analysis of proNGFybbR. The peak indicates a molecular weight of 
26,047 kDa, identifying exactly proNGFybbR. 
 
Mature neurotrophin was obtained by controlled proteolysis of the purified proNGFybbR, using 
trypsin protease. This enzyme was chosen by virtue of the specificity of its cleavage site (Lys and 
Arg). After digestion, the solution containing the mature neurotrophin was diluted in FPLC buffer 
in order to lower the ionic strength. Another step of FPLC chromatography was used for the 
purification of mature NGFybbR. 
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Figure 17. Chromatographic profile of NGFybbR purification. The enzymatic digestion produces at 
least three different protein species.  
 
Also in this case, a small aliquot of each collected fraction was analyzed by SDS-PAGE.  
 
Figure 18. SDS-PAGE analysis of FPLC fraction. Mw lane is standard molecular weights. pro and dig 
lane represent the proNGFybbR before and after digestion, without chromatographic purification 
step. The different numbers in each lane represent the corresponding FPLC fractions. Numbers in 
red represent the fractions analyzed by MS. 
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The chromatographic analysis of NGFybbR revealed the presence of at least three different 
species. In order to clarify this issue and identify the species of interest, small aliquots from three 
different fractions were analyzed by Mass spectrometry.  
 
Figure 19. Detail of chromatogram of NGFybbR. The arrows represent the fractions used for mass 
spectrometry analysis. 
 
Mass spectrometry has established the presence of 3, 2 and 4 digestion products, respectively in 
the first, second and third peak as shown in figure 20. 
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Figure 20. MS analysis of the three FPLC peaks. proNGFybbR digestion produce overall five 
different protein species. The red oval represents the species of interest (NGFybbR -2 C-Term) in 
the second peak. 
 
The protein population derived from proteolysis is composed by five different species:  
 desoctaNGFybbR -2 C-Term (13202,8 Da; pI: 8,27); this species comes from the digestion at 
the N- terminus of arginine at position 9 and of the last two amino acids at the C-terminus. 
 NGFybbR -2 C-Term (14252,6 Da; pI: 8,56); this specie comes from digestion of arginine at 
position -1, it is the protein of interest , although lacking the last two amino acids of the 
tag. 
 NGF -Tag ybbR (13261,3 Da; pI: 8,81);  this species comes from the digestion at C-terminus 
of arginine at position 118. 
 NGFybbR +R N-Term; -2 C-Term (14408,4 Da; pI: 8,8); this specie comes from the digestion 
at the N-terminus of Lysine at position -2 and of the last two amino acids of the tag.  
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 NGF +R N-Term; -Tag ybbR (13417,1 Da; pI: 9,0); this species comes from the digestion at 
the N-terminus of Lysine at position -2 and at the C-terminus of arginine at position 118 
(see Figure 21). 
 
 
Figure 21. Amino acid sequence of NGFybbR. Mature NGF sequence starts with serine at 
position 1 and end with arginine at position 118. The final eleven amino acids (DSLEFIASKLA) 
represent the ybbR tag. 
 
Given the presence of only two species in the second peak, only one of which has the tag 
necessary to the labeling reaction, it was possible to produce a pure form of fluoNGF.  
The obtained fractions of NGFybbR were joined as follows: from fraction 32 to 39 (1° peak), from 
42 to 50 (2° peak) and from 52 to 62 (3° peak). The three solutions were dialyzed overnight in 
storage buffer and subsequently aliquoted.  
fluoproNGF and fluoNGF purification 
The In vitro labeling reaction has allowed to conjugate each neurotrophin to the CoA-Alexa647 
substrate. In order to separate the fluorescent neurotrophins from those non-reacted, the 
samples were processed by cation exchange HPLC. It is important to note that the use of a 
fluorophore such as Alexa647, which possesses a negative charge, produces a shift in the elution 
time of the labelled neurotrophin compared to the unreacted ones, facilitating the separation of 
the two species. Changing in the elution time is clearly visible by comparing chromatographic 
profiles of each non-reacted versus fluorescent species. 
 43 
 
 
Figure 22. HPLC chromatograms of proNGFybbR and fluoproNGF. The standard chromatogram 
above shows the time course of HPLC separation (X axis) and the measured absorbance at 280 nm 
(Y axis). The tridimensional chromatogram below shows the time course on X axis and the 
wavelength of the signal on Y axis. The number of line in the tridimensional chromatogram is 
proportional to the intensity of the measured signal. In the chromatogram above (A), proNGFybbR 
was loaded and purified on HPLC without performing the fluorolabeling reaction. The arrow 
represent the proNGFybbR peak, which possesses 24,5 minutes as elution time. The 
chromatogram below (B) represents fluoproNGF profile. Arrows represent the absorbance (above) 
and fluorescence (below) (respectively at 280 nm and 647 nm) of fluoproNGF. The negative charge 
of Alexa647 produces a shift in the elution time of fluorescent neurotrophin (22,5 minutes) 
compared to non reacted ones. 
NGFybbR and fluoNGF present a more complex scenario. The chromatograms below show the 
three HPLC profiles of the NGFybbR species present in the first, second and third peak.  
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Figure 23. Chromatographic profiles of NGFybbR species. Each peak contains one predominant 
species, which elutes at a precise time according to its Ip. In A, B and C the chromatogram of 
NGFybbR species coming respectively from the first, second and third FPLC peak are shown. 
 
The HPLC analysis of fluoNGF species obtained by the labeling reaction performed with each FPLC 
peak has demonstrated the ability of this methodology to purify a single protein specie among a 
complex mix of digestion products. Altogether, three different species of fluoNGF can be obtained, 
in agreement with the mass spectrometry analysis. In particular: 
 The labeling performed on the first FPLC peak results in desoctaNGFybbR -2 C-Term as a 
principal fluorolabelled specie and in a small amount of fluorolabelled NGFybbR -2 C-Term 
 The labeling performed on the second FPLC peak uniquely results in NGFybbR -2 C-Term as 
a fluorescent specie 
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 The labeling performed on the third FPLC peak results in a small amount of fluorolabelled 
NGFybbR -2 C-Term and NGFybbR +R N-Term; -2 C-Term as a principal species.  
Our protein of interest (NGFybbR -2 C-Term) is present mainly in the second FPLC peak, 
moreover it is the only fluorescent specie present in this fraction. It was then possible to purify 
and use it for subsequent experiments. 
 
Figure 24. HPLC chromatograms of NGFybbR and fluoNGF coming from the first FPLC peak. A) 
Magnification of the standard chromatogram of NGFybbR. 1 and 2 represents desoctaNGFybbR -2 
C-term (main species) and NGFybbR -2 C-term, whose elution times are 11 min and 14 min 
respectively. B) Tridimensional chromatogram of fluoNGF. Both desoctaNGFybbR (1) and NGFybbR 
(1) have successfully reacted and their elution time is changed, becoming respectively 3 min and 9 
min.  
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Figure 25. HPLC chromatograms of NGFybbR and fluoNGF coming from the second FPLC peak. A) 
Magnification of the standard chromatogram of NGFybbR. 1, 2 and 3 represents NGFybbR -2 C-
term (main species), NGF –Tag ybbR and NGF +R N-term; -Tag ybbR, whose elution time are 14 
min, 16 min and 18 min respectively. B) Tridimensional chromatogram of fluoNGF. The 
fluorescence signal at 647 nm below 1 identify NGFybbR -2 C-term as unique fluorescent NGF 
species. The elution time of this species has changed from 14 min to 9 min. NGF –Tag ybbR and 
NGF +R N-term; -Tag ybbR are not able to react because of the absence of ybbR tag. It can be 
noted that their elution time is not changed.  
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Figure 26. HPLC chromatograms of NGFybbR and fluoNGF coming from the third FPLC peak. A) 
Magnification of the standard chromatogram of NGFybbR. It is shown the NGF +R N-term; -Tag 
ybbR peak (1) as main species present. B) Tridimensional chromatogram of NGF +R N-term; -Tag 
ybbR after labeling reaction. Because of the absence of the ybbR tag, this species is not able to 
react, so the elution time is not changed (18,5 min) and the fluorescence signal at 647 nm is not 
present. 
 
Interestingly, the purified fluoNGF lacks two amino acids at the C-terminus of the ybbR tag, 
however this did not seem to affect the labeling reaction.  
4.2. fluoproNGF and fluoNGF functional validation 
Clustering analysis of gene expression profiles showed that treatments with wt and fluorescent 
proNGF cluster together, while the gene expression profile obtained with wt NGF is farther away 
in the tree and is clustered together with fluoNGF. Thus, each fluoNGF and fluoproNGF 
neurotrophin induces a global gene expression pattern very similar to that of the corresponding 
unmodified neurotrophin.  
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Figure 27. Microarray analysis result. A) Hierarchical clustering tree of samples, corresponding to 
the different experimental points (for each neurotrophin type four individual PC12 cells 
administration was performed). The trees show the gene expression similarity between samples. 
The x-axis indicates the distance between samples. Euclidean distance is the chosen metric, with 
average linkage clustering, using all normalized Log2 data. B) Histogram representing the amount 
of differentially expressed mRNAs (Y axis), comparing the fluorescent vs the wild-type form of 
either NGF and proNGF, according to the Limma test. It is also shown the comparison between 
fluoNGF vs fluoproNGF and wtNGF vs wtproNGF. 2fc is two-fold change. 
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4.3. fluoproNGF degradation 
The study of intra-cellular integrity of fluoproNGF was necessary to better understand its dynamics 
and interactions with other proteins. So, fluoproNGF/fluoNGF ratio was checked at various timing 
points, spanning the duration of the neurotrophins administration in immunocytochemistry 
experiments. Integrity of purified fluoproNGF starting solution was checked via spiking it into cell 
lysate without the incubation step, thus considering it as a 0 minutes administration time. The 
cells were lysed and the fluoproNGF content was verified by SDS-PAGE.  
 
Figure 28. fluoproNGF cleavage analysis. A) SDS-PAGE of PC12 cells lysate after fluo-proNGF 
administration. 10 min, 30 min, 1h, 2h and 3h represent the periods of incubation. The input 
represents the signal of fluoproNGF spiked into untreated PC12 cell lysate. B) Histogram 
representing the ratio of precursor and mature fluorescent neurotrophins. NTs ratio was obtained 
by setting the sum of fluorescent intensities as 1. Data derive from the average of two replicas. 
The error bars of the histogram derive from the standard deviation of the data. The color code is 
green for NGF and red for proNGF. 
 
4.4. Matlab colocalization script 
In order to validate the Matlab script as a tool for the colocalization analysis, a measurement of 
the colocalization using standard glass slide for the alignment of laser was performed. 
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Figure 29. Colocalization test. The figure shows the colocalization analysis of fluorescent signals 
coming from the beads of the glass slide. The two boxes at the top show the native images 
acquired, respectively the signal emitted by 633nm laser excitation (R) and the signal emitted by 
488nm laser excitation (G). The native images processed by Gaussian smoothing are shown in the 
two blue panels at the bottom of the figure (R’ and G’). The “Composite” panel shows the 
superimposed signals (R’ in red and G’ in green). The colocalizing spots are shows in yellow. M1 
represent the Manders colocalization coefficient. 
 
Tipical readout of the Matlab script analysis is shown in figure 30. 
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Figure 30. Colocalization analysis of a cell. The figure shows the colocalization analysis of 
fluorescent signals coming from a cell. The two boxes at the top show the native images acquired, 
respectively the signal emitted by fluoNGF (R) and the signal emitted by EEA1 (G). The native 
images processed by Gaussian smoothing are show in the two blue panels at the bottom of the 
figure (R’ and G’). The “Composite” panel shows the superimposed signals (R’ in red and G’ in 
green). The colocalizing spots are show in yellow. M1 represent the Manders colocalization 
coefficient. 
 
4.5. fluoNGF vesicles are brighter than fluoproNGF vesicles 
Images analysis has shown that the vesicles that contain fluoNGF are brighter than those 
containing fluoproNGF, as shown in figure 31. 
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Figure 31. Fluorescence intensity of the vesicles containing neurotrophins. A) Typical image of a 
cell treated with fluoNGF. C) Typical image of a cell treated with fluoproNGF. B and D represent 
the corresponding images displayed in grayscale mode, with a color code identifying the 
fluorescence intensities, as shown by the scalebar at the right of each image.  
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4.6. Colocalization of fluoproNGF and fluoNGF with neurotrophic 
receptors 
In order to analyze the spatial distribution of neurotrophins and their receptors and their possible 
mutual interactions, immunocytochemistry experiments have been performed. In particular, 
fluoproNGF and fluoNGF were administered individually to differentiated PC12 cells. Three time 
points of exposure to the fluorescent neurotrophin were considered (1h, 2h and 3h). At the end of 
each time point, cells were fixed and processed according to the protocol for 
immunocytochemistry. Next, cell images were captured using a laser scanning confocal 
microscope.  
 
Figure 32. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF for one hour is shown, at the bottom, a cell incubated with fluoNGF for three hours is 
shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted by 
fluoNGF and TrkA are superimposed in Merge panel. Scale bar is 5 µm. 
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Figure 33. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoproNGF for one hour is shown, at the bottom, a cell incubated with fluoproNGF for three 
hours is shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted 
by fluoproNGF and TrkA are superimposed in Merge panel. Scale bar is 5 µm. 
 
Figure 34. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF for one hour is shown, at the bottom, a cell incubated with fluoNGF for three hours is 
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shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted by 
fluoNGF and p75 are superimposed in Merge panel. Scale bar is 5 µm. 
 
Figure 35. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoproNGF for one hour is shown, at the bottom, a cell incubated with fluoproNGF for three 
hours is shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted 
by fluoproNGF and p75 are superimposed in Merge panel. Scale bar is 5 µm. 
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Figure 36. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF for one hour is shown, at the bottom, a cell incubated with fluoNGF for three hours is 
shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted by 
fluoNGF and Sortilin are superimposed in Merge panel. Scale bar is 5 µm. 
 
Figure 37. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoproNGF for one hour is shown, at the bottom, a cell incubated with fluoproNGF for three 
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hours is shown. Bright-field illumination was shown (Trasmitted light). Fluorescent signals emitted 
by fluoproNGF and Sortilin are superimposed in Merge panel. Scale bar is 5 µm. 
 
Figure 38. Colocalization analysis of NGF and proNGF with neurotrophin receptors. Graphs show 
the average percentage of colocalization (Y axis) in the three time points analyzed (X axis). In 
particular, the left column shows the colocalization of NGF and the central column shows the 
colocalization of proNGF. In the right column, the three values of colocalization of each 
neurotrophin were connected by segments in order to visualize the global trends of colocalization. 
The color code used is green for NGF and red for proNGF. The error bars represent the standard 
error of the mean.  p is the p value. 
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4.7. Colocalization of fluoproNGF and fluoNGF with endosomal 
partners 
In order to analyze the differential association of NGF and proNGF with various proteins partners 
involved in endocytic pathways, immunocytochemistry experiments were performed. Both 
fluorescent neurotrophin was administered individually to differentiated PC12 cells for three 
different time duration (1h, 2h and 3h). The cells were then fixed and processed according to the 
protocol. Images of the cells were captured by LSCM. 
 
Figure 39. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF, at the bottom, a cell incubated with fluoproNGF. Bright-field illumination was shown 
(Trasmitted light). Fluorescent signals emitted by neurotrophin and Rab11 are superimposed in 
Merge panel. Scale bar is 5 µm. 
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Figure 40. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF, at the bottom, a cell incubated with fluoproNGF. Bright-field illumination was shown 
(Trasmitted light). Fluorescent signals emitted by neurotrophin and Rab7 are superimposed in 
Merge panel. Scale bar is 5 µm. 
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Figure 41. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF, at the bottom, a cell incubated with fluoproNGF. Bright-field illumination was shown 
(Trasmitted light). Fluorescent signals emitted by neurotrophin and Rab5 are superimposed in 
Merge panel. Scale bar is 5 µm. 
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Figure 42. Images of cells captured by confocal microscopy. At the top, a cell incubated with 
fluoNGF, at the bottom, a cell incubated with fluoproNGF. Bright-field illumination was shown 
(Trasmitted light). Fluorescent signals emitted by neurotrophin and EEA1 are superimposed in 
Merge panel. Scale bar is 5 µm. 
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Figure 43. Colocalization analysis of NGF with endosomal partners. The graphs show the average 
percentage of colocalization (Y axis) in the three time points analyzed (X axis). The endosomal 
partner analyzed was indicated in the upper-left of each graph. The error bars represents the 
standard error of the mean.  p is the p value. 
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Figure 44. Colocalization analysis of proNGF with endosomal partners. The graphs show the 
average percentage of colocalization (Y axis) in the three time points analyzed (X axis). The 
endosomal partner analyzed was indicated in the upper-left of each graph. The error bars 
represents the standard error of the mean.  p is the p value. 
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Figure 45. Comparison between the colocalization of NGF and proNGF with the endosomal 
partners. The percentages of colocalization have been obtained by averaging the values from all 
the three time points. In A, B, C and D the average percentage of colocalization of both 
neurotrophins with respectively Rab11, Rab7, Rab5 and EEA1 are shown. The error bars 
represents the standard error of the mean.  p is the p value. The color code used is green for NGF 
and red for proNGF.  
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5. Discussion 
Axonal trafficking of NGF has been studied over the last 20 years. Given the peculiarities of their 
physiology, the study of neurotrophins requires precautions. The labeling approaches used for this 
purpose include both chemical reactions directed to various active groups of the protein and site-
specific methodologies. Although the site-specific labeling is an optimal strategy, preventing 
undesired structural alterations, in the past this approach has been chosen to combine the 
neurotrophins to fluorescent particles such as quantum dots49. These latter have very good optical 
properties, but possess dimensions ranging from 15 to 20 nm, therefore much bigger than the 
molecules they are supposed to label50. Then comes the need to develop a labeling methodology 
which has a minimum impact on the structure of neurotrophins, and also that is sufficiently 
versatile to achieve diverse purposes such as tracking experiments or for the isolation of 
endosomes. 
This work provides a new methodology for the labeling of neurotrophins. The strategy adopted 
has numerous advantages. Given the small size of the amino-acidic tag and of the fluorescent 
conjugate used, in fact, this approach is minimally invasive and preserves the correct functionality 
of both fluoNGF and fluoproNGF, as proved by DNA microarray analysis (see figure 27). It is a site-
specific modification, therefore allowing the production of a homogeneous population of 
neurotrophins, ensuring maximum experimental reproducibility. Moreover, the control of the 
labeling stoichiometry provides important quantitative information about the transport of these 
proteins within neurons. Finally, the used tag is very versatile, for example combining Coenzyme-A 
with magnetic beads, it would be possible to isolate the endosomes that containing 
neurotrophins, and subsequently analyze these organelles via proteomic approaches in order to 
characterize different protein populations.  
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Figure 46. Schematization of labeling strategy. A) Cartoon depicting the two-steps labeling 
strategy. Structure of human NGF (blue ribbon, PDB 1SG1) with overlaid, in grey, the pro-peptide 
domain, ybbR tag is shown in red (middle), the complete structural formula of Alexa647-
maleimide-phosphopantetheinyl is added, highlighted in green (right). B) Scheme of proNGF 
sequence with highlighted tag insertion site. C) ybbR tag amino acid sequence. Serine residue 
involved in labeling reaction is highlighted in red.  
In order to obtain fluorescent proNGF and NGF, the strategy chosen is composed of two steps: i) 
insertion of the tag ybbR within the sequence encoding the neurotrophin, ii) site-specific labeling 
by the use of CoA-Alexa647 substrate. 
Microarray analysis has been used as a tool to validate the functionality of both fluoNGF and 
fluoproNGF. This assay is able to identify the distinct mRNA expression patterns induced by NGF 
and proNGF51. The analysis has shown that both fluoNGF and fluoproNGF are fully functional and 
retain their specific activities, producing peculiar gene-expression patterns, similar to those of the 
wt counterpart. 
After obtaining the fluorescent neurotrophins, these were individually administered to 
differentiated PC12 cells. The acquired images showed important differences between proNGF 
and NGF. In fact, the fluorescent spots that identify NGF are much brighter than those that identify 
proNGF, in agreement with the results of De Nadai et al.44 . This difference is due to a different 
average number of neurotrophins transported by each vesicle in the two cases, respectively 4 
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dimers for NGF and 1 dimer for proNGF in the case of vesicles transported in the axon of DRG 
neurons. It should also be considered that the NGF degradation is very slow, so it is conceivable 
that the neurotrophin accumulates in the MVBs and in the lysosomal compartments52. 
The results presented in this work provide also a quantitative analysis of the colocalization of both 
proNGF and NGF with their respective protein partners. In principle, one might expect to observe, 
for example in the case of NGF and TrkA, a percentage of colocalization of approximately 100%, 
while we always measured colocalization percentages below 50%. However, we must consider the 
technical limits introduced by the binding of an antibody with its antigen. This principle can be 
applied to all of the colocalization experiments performed. In addition, it is conceivable that the 
NGF can travel inside of the cell in the absence of TrkA, for example joining p7553. Moreover, in a 
colocalization experiment, Delcroix and colleagues reported that, of the spots positive for NGF, 
only 55% colocalized with TrkA in DRG neurons54.  
It is important to note that despite this limit, the comparison between the percentages of 
colocalization of proNGF and NGF with their possible molecular interactors can be readily 
compared one to each other.  
In this work it was observed that in PC12 cells, the proNGF is present both in the intact and 
cleaved form. The mature NGF produced by proNGF cleavage is a consistent part of the entire 
fluoproNGF administered, reaching 50% of the total neurotrophins population after three hours of 
incubation. However, processed proNGF must be considered as a part of the initial un-processed 
population. In fact, despite proNGF can be physiologically cleaved, it retains its specific action. So 
the enzymatic processing of precursor NGF is a part of its functional action. These specific 
properties are reflected in the microscopy analysis. Moreover, we never observed any fluoproNGF 
spot with a fluorescence intensity comparable to that of fluoNGF spots. For this reason, the 
percentage of colocalization attributable to cleaved fluoproNGF has been considered as an 
integral part of that of the total fluoproNGF. 
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The major findings highlighted by this analysis are:  
 the percentages of colocalization of either proNGF or NGF 
with a receptor significantly changes over time, with the 
exception of: NGF-p75, NGF-Sortilin and proNGF-TrkA 
 proNGF colocalizes more than NGF with TrkA,  at 1 hour of 
administration 
 in general, after one hour of administration, proNGF 
colocalizes more than NGF with all the three receptors 
 
The change in the percentage of colocalization during the time of exposure to the neurotrophin is 
a phenomenon that can be due to a greater or lesser availability of a receptor with respect to 
another on the cell membrane. It is interesting to note that the variation of the percentage of 
colocalization during the time of administration is neurotrophin/receptor specific. In fact there are 
no changes in colocalization between: NGF and p75, NGF and sortilin, proNGF and TrkA. These 
results confirm the specificity of the two neurotrophins for different receptors. Moreover, given 
the static nature of these experiments, it is difficult to make assumptions about the dynamics of 
these interactions, which would require live imaging experiments. Surprisingly, it was observed 
that proNGF shows a percentage of colocalization higher than that of NGF in regard to all the 
three receptors at one hour of exposure to the neurotrophin. Although this may sound surprising 
for the proNGF/TrkA case, it must be considered that the proneurotrophin has a dynamic of 
internalization slower than that of the mature form, this produces a strong membrane labeling 
that could affect the percentage of colocalization at short incubation times.  
In this work it was carried out a quantitative analysis of the colocalization of both NGF and proNGF 
with endosomal partners such as: Rab11, Rab7, Rab5 and EEA1. These proteins were chosen 
because of their constitutive role in common endocytic pathways. This analysis has highlighted 
some important aspects about the intracellular trafficking of both neurotrophins. First, it’s 
important to note that the average percentage of colocalization, in all the observed cases, does 
not change over time, contrary to what was seen in the case of the neurotrophic receptors. This 
aspect is consistent with the constitutive role of these endosomal proteins, and with their not-
direct involvement in the signaling of neurotrophins. Furthermore, it is important to note that the 
average percentage of colocalization of proNGF with all the endosomal partner is about half of 
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that observed for NGF. This result should be viewed with caution, because the Rab proteins family 
includes a large number of members, many of which were not considered. It is possible, therefore, 
that the proNGF possesses an intracellular traffic different from that of NGF. Of particular interest 
is the colocalization of proNGF with Rab5. This endosomal protein is considered a master regulator 
of the formation and sorting of early endosome. There are three isoforms of Rab5 (A, B and C). It 
was observed that Rab5A and Rab5B are directly involved in the Epidermal growth factor receptor 
(a prototype tyrosine kinase receptor) trafficking, while Rab5C have a compensatory function55. 
The anti-Rab5 antibody used in this work recognize specifically the isoform A, so it is possible that 
proNGF associates preferentially with another Rab5 isoform. The distribution and the traffic of 
NGF and proNGF in different endosomal populations could be at the basis of their specific and 
opposed activity.   
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